Cargando…

Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control

Coronavirus disease 2019 (COVID-19) is associated with a high risk of mortality and complications in patients with diabetes mellitus. Achieving good glycemic control is very important in diabetic patients to reduce complications and mortality due to COVID-19. Recent studies have shown the mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanan, Niya, Naik, Dukhabandhu, Sahoo, Jayaprakash, Kamalanathan, Sadishkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724202/ https://www.ncbi.nlm.nih.gov/pubmed/36483108 http://dx.doi.org/10.5501/wjv.v11.i6.399

Ejemplares similares

Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence
por: Roy, Ayan, et al.
Publicado: (2021)

Growth hormone and gastrointestinal malignancy: An intriguing link
por: Palui, Rajan, et al.
Publicado: (2023)

Treatment on Nature’s lap: Use of herbal products in the management of hyperglycemia
por: Giri, Somdatta, et al.
Publicado: (2023)

Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022)

Pediatric Adrenocortical Oncocytoma presenting as Cushing’s Syndrome and Peripheral Precocious Puberty: A Case Report and Review of Literature*
por: Narayanan, Niya, et al.
Publicado: (2021)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

The Risk of Fractures in Primary Hyperparathyroidism: A Meta‐Analysis
por: Narayanan, Niya, et al.
Publicado: (2021)

Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment
por: Florentin, Matilda, et al.
Publicado: (2022)

Timing of osteoporosis therapies following fracture: the current status
por: Palui, Rajan, et al.
Publicado: (2022)

Adrenal crisis in a patient with APS2 due to COVID-19: A case report
por: Suryadevara, Varun, et al.
Publicado: (2022)

Islet cell dysfunction in patients with chronic pancreatitis
por: Roy, Ayan, et al.
Publicado: (2020)

Diabetes and pancreatic cancer: Exploring the two-way traffic
por: Roy, Ayan, et al.
Publicado: (2021)

ODP166 Autoantibody Positivity and Random C-peptide Profile in Young Ethnic South Indian Population with Diabetes Mellitus
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2022)

Abstract 128: Thyroid function abnormalities in hospitalized patients with COVID-19 infection – A cross-sectional study
por: Rashmi, K G, et al.
Publicado: (2022)

Abstract 145: Etiological profile of precocious puberty: A JIPMER experience
por: Suryadevara, Varun, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic Dyslipidaemia
por: Bage, Isaac J., et al.
Publicado: (2023)

Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease
por: Ikeda, Yuka, et al.
Publicado: (2021)

Clinical Features of Unrecognized Congenital Adrenal Hyperplasia Due to 17α-hydroxylase Deficiency Since Adolescence: A Case Report
por: Rashmi, KG, et al.
Publicado: (2023)

Abstract 41: Effect of zoledronic acid on bone mineral density in Indian postmenopausal osteoporotic women with and without diabetes – A prospective cohort study
por: Merugu, Chandhana, et al.
Publicado: (2022)

Dipeptidyl peptidase‐4 inhibitors and prevention of bone fractures: Effects beyond glyemic control
por: Yabe, Daisuke, et al.
Publicado: (2012)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

THU416 Trabecular Bone Score, Bone Mineral Density, And Fractures In Patients Of Chronic Kidney Disease With And Without Diabetes Mellitus
por: Suryadevara, Varun, et al.
Publicado: (2023)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Primary hyperparathyroidism presenting as acute pancreatitis: An institutional experience with review of the literature
por: Rashmi, K G, et al.
Publicado: (2022)

Dipeptidyl Peptidase-4 Inhibitor (Vildagliptin) Improves Glycemic Control After Meal Tolerance Test by Suppressing Glucagon Release
por: Okamoto, Aki, et al.
Publicado: (2014)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
por: Garg, Vishvas
Publicado: (2011)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
por: Singh, Awadhesh Kumar
Publicado: (2014)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
por: Shoombuatong, Watshara, et al.
Publicado: (2015)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
por: Kim, Kwang-il
Publicado: (2018)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
por: Yazbeck, R., et al.
Publicado: (2021)

Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
por: Yin, Ruili, et al.
Publicado: (2022)

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2018)

Abstract 134: Clinical profile of AAA syndrome a case series: A retrospective study
por: Venkatesh,, et al.
Publicado: (2022)

Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot
por: Kalayarasan, Raja, et al.
Publicado: (2021)

Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
por: Kanasaki, Keizo
Publicado: (2019)

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
por: Hong, Sangmo, et al.
Publicado: (2022)

Non-medicalization of medical science: Rationalization for future
por: Mittal, Madhukar, et al.
Publicado: (2022)

The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
por: Panchapakesan, Usha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q9j6pqpmotrsmv7kd0l24hfpki